Cargando…
Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
Nano-engineered mesenchymal stem cells (nano-MSCs) are promising targeted drug delivery platforms for treating solid tumors. MSCs engineered with paclitaxel (PTX) loaded poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) are efficacious in treating lung and ovarian tumors in mouse models. The qua...
Autores principales: | Cheng, Shen, Nethi, Susheel Kumar, Al-Kofahi, Mahmoud, Prabha, Swayam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828117/ https://www.ncbi.nlm.nih.gov/pubmed/33445681 http://dx.doi.org/10.3390/pharmaceutics13010092 |
Ejemplares similares
-
Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer
por: Layek, Buddhadev, et al.
Publicado: (2020) -
Enhancing Anticancer Efficacy of Chemotherapeutics Using Targeting Ligand-Functionalized Synthetic Antigen Receptor-Mesenchymal Stem Cells
por: Nethi, Susheel Kumar, et al.
Publicado: (2023) -
Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023) -
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing
por: Prabha, Swayam, et al.
Publicado: (2023) -
In vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics
por: Ren, Guolian, et al.
Publicado: (2020)